March 11, 2021

March 11, 2021

ASH 2020: Dr. Christopher Pleyer Discusses the Effect of Bruton Tyrosine Kinase Inhibitors on the Efficacy of Adjuvanted Recombinant Hepatitis B and Zoster Vaccines in Patients with Chronic Lymphocytic Leukemia (CLL)

Dr. Koffman and Dr. Pleyer discuss the findings from two studies that were previously mentioned in earlier stages of the trial that can be found here. Dr. Pleyer looked at immune response rates in CLL patients after receiving the HEPLISAV-B for preventing hepatitis, and the Shingrix vaccine for preventing

March 11, 2021

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Biomarker Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology’s (ASH) 2020 conference, there was research on looking at the genome of CLL and how different genetic markers might have predictive and value. Dr. Brian Koffman, Chief Medical Officer and Executive Vice President of CLL Society, interviewed Dr. Adrian Wiestner, a senior investigator at

March 11, 2021

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

Interim Public Health Recommendations for People Fully Vaccinate against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

March 11, 2021

ASH 2020: Dr. Christopher Pleyer Discusses the Effect of Bruton Tyrosine Kinase Inhibitors on the Efficacy of Adjuvanted Recombinant Hepatitis B and Zoster Vaccines in Patients with Chronic Lymphocytic Leukemia (CLL)

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Biomarker Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT